Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- First CRISPR treatment for blood diseases shows early benefits in two patientson November 19, 2019 at 4:06 am
Since her treatment in July, the sickle cell patient, Victoria Gray, has not suffered any vaso-occlusive crises, in which sickled blood cells basically get stuck in blood vessels, causing severe pain ...
- What to know about colon painon November 18, 2019 at 9:07 pm
This can lead to bleeding and pain with bowel movements. People with constipation may need more fiber in their diet. They can help soften the stool and allow it to pass more easily by: consuming high ...
- Neuropathy patient says numbness and pain are gone with advanced treatmenton November 18, 2019 at 3:07 pm
HOUSTON — Do you suffer from nerve pain daily? If medications are masking the symptoms and not improving your quality of life, there is hope. A proprietary treatment by Dr. Bao Thai of Advanced Nerve ...
- Stem Cell Treatment Relieves Chronic Painon November 18, 2019 at 10:23 am
Learn more about a revolutionary treatment giving relief to chronic pain sufferers. How stem cells are changing the game when it comes to treating pain. WEBSITE: Buckeye Physical Medicine and Rehab ...
- Advanced breast cancer patients denied access to life-prolonging drugs and opioidson November 18, 2019 at 5:52 am
We need to ensure that appropriate pain medications and other symptom interventions are available to them. "We acknowledge that the misuse of opioids is a big problem, particularly in the United ...
- Chronic Pain Treatment Market by Product, by...on November 17, 2019 at 11:29 pm
New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chronic Pain Treatment Market by Product, by Indication, by Application, by Distribution Channel, by ...
- Chronic Pain Treatment Market to Garner Overwhelming Hike In Revenues by 2026on November 17, 2019 at 7:24 pm
Nov 17, 2019 (Market Prediction via COMTEX) -- This report focuses on Chronic Pain Treatment volume and value at global level, regional level and company level. From a global perspective, this report ...
- Dry needling offers alternative to pain medicationson November 16, 2019 at 10:10 pm
Dry needling employs a Western philosophy of attacking pain trigger points, the bands of tight fascia or muscle commonly known as knots. Originally, anesthesia was injected through hypodermic needles.
- Regular use of prescription drugs for pain and sleep increases frailty risk by 95 percenton November 14, 2019 at 12:45 am
Researchers from the Oregon Research Institute (ORI) and Florida Atlantic University (FAU) are the first to demonstrate statistically significant links between self-reported regular use of ...
via Bing News